MORE►
cancer
Perimeter Chief Medical Officer Ted James MD [Photo: LinkedIn]
Perimeter Medical Imaging AI Names Noted Oncologist as Chief Medical Officer
by Lance Murray | Aug 28, 2025
The Dallas- and Toronto-based company said that Ted James' perspective as a cancer surgeon and health system executive, combined with his experience in healthcare innovation, will support its growth as it advances toward commercialization.
by Lance Murray |
Jul 2, 2025
UTA and UT Southwestern researchers have built BIT, a new computational framework that helps scientists identify the proteins that switch genes on and off in cancer and other diseases. The work could pave the way to more targeted treatments and boost gene research accuracy.
MORE►
by Nicole Ward, DRC Data Journalist |
Jun 24, 2025
At its Dallas Design District grand opening, Koya Medical marked the official move of its headquarters from California—bringing with it a wearable alternative to wall-powered compression therapy for vascular patients. “This is something that is different from anything that is out there,” says vascular surgeon and new CMO Tom Maldonado.
MORE►
by Lance Murray |
Jan 23, 2025
Founded in 2012, Universal DX is focused on "cracking cancer’s code" via its multi-omics and machine learning models. Starting with colorectal cancer, it's building a "multi-cancer platform" that can ID the unique DNA regions associated with different types of cancers.
MORE►
UTSW Says Experimental Compound Kills Cancer, Spares Immune Cells
by Lance Murray | Jul 17, 2024
Researchers at UT Southwestern Medical Center in Dallas have identified a compound that selectively eliminates cancer cells while sparing immune cells in a form of cell death known as ferroptosis, according to a news release.
UTSW said the findings, published in Science Translational Medicine earlier this year, could lead to new treatments for a wide variety of cancer types....
MORE►
by Lance Murray |
Feb 27, 2024
Included in the 12 Dallas-area funding awards is a $4 million Rising Star grant to bring Stefan Gloeggler, Ph.D., to UT Southwestern Medical Center from the Max Planck Institute of Multidisciplinary Sciences in Göttingen, Germany.
MORE►
by Lance Murray |
Feb 22, 2024
Carson Leslie Foundation, Grant Halliburton Team Up to Support Kids With Cancer—And Deliver Smiles
MORE►
by Lance Murray |
Dec 6, 2023
UT Arlington principal investigator Dr. Suvra Pal said that previous studies modeling the probability of a cancer cure—also called the cure rate—"used a generalized linear model." The new statistical modeling method published by Pal and his student is said to be 30% more effective in predicting who will be cured of cancer and who will need further treatment.
MORE►
Illustration: bsd555/iStock
CPRIT Awards $9.5M in Cancer Research Grants to SMU and Dallas’ Baylor Research Institute
by Lance Murray | Aug 17, 2023
The 29 new grants approved by CPRIT's Oversight Committee include the first CPRIT Scholar award to Southern Methodist University in Dallas and state funding for Dallas' Baylor Research Institute to join a major National Cancer Institute study.
MORE►
by Lance Murray |
Mar 13, 2023
“Our researchers continue to push the envelope on developing a better understanding of cancer and new ways to help cancer patients in Texas and beyond,” said Center Director Carlos L. Arteaga, M.D.
MORE►
by Lance Murray |
Mar 9, 2023
The researchers discovered how healthy bacteria can escape the intestine, travel to lymph nodes and cancerous tumors elsewhere in the body, and boost the effectiveness of certain immunotherapy drugs. “Now we understand that mechanism much better and, in the future, hope to use this knowledge to better fight cancer," said UT Southwestern's Andrew Y. Koh, M.D.
MORE►
by Lance Murray |
Mar 7, 2023
NanOlogy said the new patent covers a method of treating cancer by intratumoral administration of large surface area microparticle taxanes in combination with systemic administration of immune checkpoint inhibitors. “The goal is to identify which combinations can increase the immune response, thereby increasing the overall solid tumor response to treatment," said NanOlogy Chief Medical Officer Gere DiZerega.
MORE►
Financial Strategies Acquisition Corp. Acquires Preclinical Pharma Company
by Lance Murray | Feb 15, 2023
Dallas-based Financial Strategies Acquisition Corp. has acquired Texas-based preclinical pharmaceutical company Austin Biosciences Corp.
Financial Strategies is a special purpose acquisition company led by CEO Alexander V. Schinzing. It said that upon the deal’s closing, Austin Biosciences will become a wholly owned subsidiary of the company.
Earlier this month, Financial Strategies announced that its board approved an extension of the period of time available to consummate the deal by one month from Feb....
MORE►
by Kevin Cummings |
Jun 23, 2022
Two giants in their industry are teaming up to accelerate cancer research. The new joint venture is an "important step forward" to increase access to clinical trials, says McKesson CEO Brian Tyler, McKesson CEO.
Separate from the joint venture deal, McKesson will acquire Genospace, a personalized precision medicine platform that’s part of HCA’s research institute.
MORE►
by Kevin Cummings |
Jun 2, 2022
Instead of shipping a patient's blood to a lab for customized cell therapy, Lupagen does the procedure "in vivo," using a dialysis-like treatment at the patient's bedside. Now it's collaborating with Umoja Biopharma to use its drug-delivery tech to place targeted immunotherapies in patients.
“We're able to deliver different types of gene therapies in a closed system," Lupagen's CEO says, calling the tech a "bridge to the future."
“We're able to deliver different types of gene therapies in a closed system," Lupagen's CEO says, calling the tech a "bridge to the future."
MORE►
by David Seeley |
Aug 16, 2021
Stelfonta received FDA approval last November to treat dogs with non-metastatic, skin-based mast cell tumors (MCTs)—the most common malignant skin tumor in dogs. The injection is now available at vet clinics across the U.S., with an 88% "satisfactory experience" rate to date.
MORE►
![Erica Kosemund, Chief Brand Officer, Choctaw Nation of Oklahoma; Gillian Breidenbach, Chief Partnership Officer, North Texas FWC Organizing Committee; Chief Gary Batton, Chief of Choctaw Nation of Oklahoma; Monica Paul, Executive Director of Dallas Sports Commission and President of North Texas FWC Organizing Committee; John Hobbs, Senior Executive Officer of Communications, Choctaw Nation of Oklahoma; and Heidi Grant, Senior Executive Officer of Commerce Administration, Choctaw Nation of Oklahoma, celebrate Choctaw Casinos & Resorts becoming an Official Dallas World Cup 2026 Host City Supporter. [Photo: North Texas FWC Organizing Committee/Choctaw Casinos & Resorts]](https://s24806.pcdn.co/wp-content/uploads/2025/12/FIFA-Choctaw-dec-2025.jpg)
